Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Vaccine maker stocks fall
Moderna And Other Vaccine Maker Stocks Tumble After Trump Taps RFK Jr. As HHS Head
RFK Jr. has developed a reputation as a vaccine skeptic and pushed conspiracy theories including one linking vaccines to autism, which has been refuted by multiple major health organizations.
Vaccine maker stocks fall after conspiracy theory-spreading RFK Jr. tapped to lead health department
Shares of COVID vaccine manufacturers Moderna and Pfizer fell early Friday morning, down 4% and 4.3% respectively.
Trump Taps Vaccine Skeptic RFK Jr. to Lead HHS. Moderna and Novavax Stocks Slide.
Donald Trump nominated Robert F. Kennedy Jr., a vaccine skeptic and harsh critic of federal health agencies, to be his Secretary of Health and Human Services. Trump announced the nomination in a post on Truth Social.
3d
Moderna, with aid of TBWA\Chiat\Day, is making mRNA science exciting & accessible
With the help of TBWA\Chiat\Day New York, pharma giant Moderna is demystifying mRNA science for the average consumer. This ...
11d
on MSN
Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold
Moderna said its newest Covid vaccine saw benefits after winning approval in the U.S. three weeks earlier than the last ...
9d
Canada approves Moderna's RSV vaccine for those age 60 and older, company says
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
FiercePharma
11d
Moderna disappoints in RSV debut, squares up with Pfizer in COVID-19 vaccine sales
Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...
Benzinga.com
10d
Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn
BofA Securities cuts
Moderna
's price target from $110 to $90 due to
vaccine
sales concerns.
Moderna
faces tough ...
Reuters on MSN
10d
Canada approves Moderna's RSV vaccine for adults aged 60 and older
Nov 8 (Reuters) -
Moderna
(MRNA.O), opens new tab said on Friday Canada's health regulator has approved its
vaccine
for ...
12d
Moderna’s Bancel steps down as sales chief, keeps CEO role
Stephane Bancel is stepping down as chief commercial officer of Moderna Inc., according to a person familiar with the matter.
3d
Moderna, Novavax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official
Vaccine stocks slid late Thursday as reports stated noted anti-vaccine politician Robert Kennedy Jr. will serve as the next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback